Skip to main content

Interviews

Dr Edward Kim
Sponsored Interview
10/17/2024
Edward Kim, MD, from Mount Sinai Health System, recently shared his views on replacing his aging imaging equipment to improve the efficiency of the interventional radiology suite at Mount Sinai.
Edward Kim, MD, from Mount Sinai Health System, recently shared his views on replacing his aging imaging equipment to improve the efficiency of the interventional radiology suite at Mount Sinai.
Edward Kim, MD, from Mount Sinai...
10/17/2024
Vascular Disease Management
Q&As
03/25/2024

Featuring Murat Dökdök, MD

Featuring Murat Dökdök, MD
Dr Murat Dökdök discusses the importance of compliance with interventional oncology accreditation standards among interventional radiologists.
Dr Murat Dökdök discusses the importance of compliance with interventional oncology accreditation standards among interventional radiologists.
Dr Murat Dökdök discusses the...
03/25/2024
IO Learning
Constantino Peña, MD, Miami Cancer Institute
Videos
03/21/2024

Featuring Constantino Peña, MD

Featuring Constantino Peña, MD ...
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses the importance of a multidisciplinary approach within the field of interventional oncology.
Constantino Peña, MD, discusses...
03/21/2024
IO Learning
Jack Jennings, MD, PhD, Washington University in St Louis
Videos
02/06/2024
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting, Jack Jennings, MD, PhD, discussed the role of the interventional oncologist when treating primary or metastatic sarcomas of the bone or soft tissue.
At the 2024 SIO Annual Meeting,...
02/06/2024
IO Learning
Riccardo Lencioni, MD, University of Pisa School of Medicine
Videos
01/23/2024
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.
Ricardo Lencioni, MD, shares...
01/23/2024
Oncology
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
Interview
12/08/2023
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview,...
12/08/2023
IO Learning
Dr. Riad Salem
Interview
12/07/2023
In this interview with Riad Salem, MD, Chief of Vascular and Interventional Radiology in the Department of Radiology at Northwestern Medicine, we discuss the future of IO, unique approaches to Y-90, and what's next for the interventional...
In this interview with Riad Salem, MD, Chief of Vascular and Interventional Radiology in the Department of Radiology at Northwestern Medicine, we discuss the future of IO, unique approaches to Y-90, and what's next for the interventional...
In this interview with Riad...
12/07/2023
IO Learning
Dr. Edward Kim
CIO2023 Highlights
12/06/2023
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr....
12/06/2023
IO Learning
Dr. AJ Gunn Unmasked
Interview
11/07/2023
In this interview, Dr. AJ Gunn shares insights and lessons about his profession and passions.
In this interview, Dr. AJ Gunn shares insights and lessons about his profession and passions.
In this interview, Dr. AJ Gunn...
11/07/2023
IO Learning
Dr. Ripal Gandhi HCC
Interview
10/25/2023
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM,...
10/25/2023
IO Learning